Results 31 to 40 of about 393,475 (314)

Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries

open access: yesBMC Pharmacology and Toxicology, 2017
Background Poor drug quality is a matter of serious concern, especially in countries where drug regulation and law enforcement are constrained by limited resources.
Mohammad Sofiqur Rahman   +9 more
doaj   +1 more source

Illusions Clouding Decision-Making: How the Justice System Fails to Understand the Illicit Drug Market

open access: yesJournal of Illicit Economies and Development, 2019
This paper reviews some of the main research on drug law enforcement in Brazil since the 2006 Drug Law came into force, noting a clear and constant pattern of police and judicial focus directed at retail drug trafficking, decisively impacting current ...
Luiz Guilherme Mendes de Paiva   +1 more
doaj   +1 more source

Factors associated with delayed diagnosis of Crohn’s disease: A systematic review and meta-analysis

open access: yesHeliyon, 2023
Background: Delayed diagnosis is a major barrier to the effective management of Crohn's disease (CD). Several studies have investigated factors responsible for delays in diagnosis, but no meta-analyses have systematically assessed the impact of these ...
Jinping Xie   +3 more
doaj   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen   +11 more
wiley   +1 more source

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock   +4 more
wiley   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Residents’ preferences for inclusive commercial supplementary medical insurance: a discrete choice experiment

open access: yesHealth Economics Review
Background In China, inclusive commercial supplementary medical insurance (ICSMI) has developed rapidly, and the size of the insured population is critical for its long-term sustainability.
Yeyi Feng   +5 more
doaj   +1 more source

ORPHAN DRUG POLICY

open access: yesInnovare Journal of Life Sciences, 2020
Pharmaceutical industry is crucial for mankind and contributes in some way in socio economic development of the society through jobs, community welfare, and supply chains. Indian pharmaceutical companies are one of the largest markets in the world, estimated 10% of global production and 2% of world market.
openaire   +3 more sources

National drug policy 2015 to 2020 [PDF]

open access: yes, 2015
Overview Over a lifetime, 44 percent of New Zealanders will try an illegal drug and 93 percent will drink alcohol.  While not every instance of alcohol and other drug use is harmful, the effects of these substances can be significant.
Ministry of Health (New Zealand)
core  

Home - About - Disclaimer - Privacy